Beyond Oil, whose shares are listed as BOIL on the Toronto Stock Exchange and BEOLF on the OTCQB, traded at $2.01 Canadian dollars on Tuesday, up 0.5% on the day, while its U.S. over-the-counter quotation stood near $19.25. The stock remains down roughly 79% from its 52-week high of $93.70, with year-to-date and six-month declines of 59% and 46%, respectively. The company’s market capitalization stands at approximately $336 million.
At the Lytham Partners 2026 Consumer & Technology Investor Summit, executives emphasized that the company’s growth trajectory hinges on scaling the deployment of its patented oil treatment product. Robert Kiesman, senior vice president and director, described the offering as a white powder applied once daily to fryer oil, designed to extend oil life by three to ten times while reducing trans fats, acrylamide, accumulated metals, and sludge. The product is FDA-approved and targets large multinationals, mid-market chains with 200 to 2,000 locations, and small operators with one to ten sites.
Michael Nemirow, president of North America, noted that operational savings range from $5,000 to $10,000 per location annually, alongside logistical and food-quality improvements that have turned restaurant staff into advocates. The sales cycle currently spans several months but is expected to compress to about three months as brand recognition grows. Beyond Oil’s manufacturing base in Israel is described as sufficient to support near-term expansion.
Harel Insurance invested ILS 17 million in equity and secondary purchases over the prior year, reflecting investor interest despite the stock’s steep decline. Analyst Adam Lowenstein of Lytham Partners moderated the discussion, highlighting the dual focus on health and cost efficiency as central to the company’s value proposition.
